ROCALTROL Side Effects

6918104-8 | Confusional State, Hypercalcaemia
on Jul 22, 2010 Female patient from SPAIN , 87 years of age, was diagnosed with renal failure chronic and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hypercalcaemia. Rocaltrol dosage: (0.5 Mg Oral). During the same period patient was treated with MASTICAL (MASTICAL CALCIUM CARBONATE) (NOT SPECIFIED) ((df)) (View Mastical (mastical-calcium Carbonate) (not Specified) Review and Mastical (mastical-calcium Carbonate) (not Specified) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ARANESP (View Aranesp Review and Aranesp Label ), DERMATRANS /00003201/ (View Dermatrans /00003201/ Review and Dermatrans /00003201/ Label ), DIOVAN (View Diovan Review and Diovan Label ), EUTIROX (View Eutirox Review and Eutirox Label ), LOBIVON (View Lobivon Review and Lobivon Label ), SEGURIL (View Seguril Review and Seguril Label ). Patient was hospitalized.

6897585-2 | Fractured Coccyx, Lumbar Vertebral Fracture, Pathological Fracture
Patient was taking Rocaltrol (View Usage). Patient had the following side effects: fractured coccyx, lumbar vertebral fracture, pathological fracture on Jul 14, 2010 from CHINA Additional patient health information: Female patient , 80 years of age, weighting 125.7 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Rocaltrol dosage: 0.25 Ug Qd Oral. During the same period patient was treated with D CAL CALCIUM SUPPLELMENT WITH VITAMIN D (View D-cal-calcium Supplelment With Vitamin D Review and D-cal-calcium Supplelment With Vitamin D Label ). Patient was hospitalized.

6765954-7 | Dizziness, Orthostatic Hypotension
Adverse event was reported on May 26, 2010 by a Male patient taking Rocaltrol (View Usage) (Dosage: 1 Rg Daily Oral) was diagnosed with calcium metabolism disorder, medical diet and. Location: MALAYSIA , 58 years of age, After Rocaltrol was administered, patient had the following side effects: dizziness (What is dizziness?), orthostatic hypotension. During the same period patient was treated with CALCIUM LACTATE (CALCIUM LACTATE) (1 G Qd Oral) (View Calcium Lactate (calcium Lactate) Review and Calcium Lactate (calcium Lactate) Label ).

6696946-4 | Patella Fracture
on Apr 08, 2010 Female patient from CHINA , 62 years of age, weighting 99.21 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: patella fracture. Rocaltrol dosage: (0.25 ?g Qd Oral), (25 ?g Qd Oral). During the same period patient was treated with CALCIUM MAGNESIUM (View Calcium Magnesium Review and Calcium Magnesium Label ). Patient was hospitalized.


6647978-3 | Hypercalcaemia, Incorrect Dose Administered, Infarction, Nodule, Pancreatic Pseudocyst, Parathyroid Disorder, Parathyroid Tumour Benign, Renal Failure Acute
on Mar 03, 2010 Female patient from JAPAN , weighting 112.9 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). Patient had the following side effects: hypercalcaemia, incorrect dose administered, infarction, nodule, pancreatic pseudocyst, parathyroid disorder (What is parathyroid disorder?), parathyroid tumour benign, renal failure acute. Rocaltrol dosage: 0.5 Ug Bid Oral. During the same period patient was treated with GLAKAY (View Glakay Review and Glakay Label ), ETIDRONATE DISODIUM (View Etidronate Disodium Review and Etidronate Disodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6588775-7 | Altered State Of Consciousness, Arthralgia, Decreased Appetite, Delirium, Dysarthria, Hypercalcaemia, Somnolence, Vertigo
Patient was taking Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: altered state of consciousness, arthralgia, decreased appetite, delirium, dysarthria, hypercalcaemia, somnolence, vertigo on Jan 27, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with hyperparathyroidism secondary and. Rocaltrol dosage: 1 Ug 1x/week Intravenous (not Otherwise Specified). Patient was hospitalized.

6552047-7 | Blood Calcium Decreased, Cardiac Arrest
Adverse event was reported on Jan 07, 2010 by a Male patient taking Rocaltrol (View Usage) (Dosage: Df) . Location: UNITED STATES , 33 years of age, Patient experienced the following unwanted or unexpected effects: blood calcium decreased, cardiac arrest (What is cardiac arrest?). Patient was hospitalized.

6337151-0 | Abdominal Pain, Abdominal Sepsis, Anuria, Aspartate Aminotransferase Increased, Blood Creatine Increased, Blood Lactate Dehydrogenase Increased, Cardiac Arrest, Hepatotoxicity
on Aug 13, 2009 Female patient from GERMANY , 62 years of age, was treated with Rocaltrol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal sepsis, anuria, aspartate aminotransferase increased, blood creatine increased, blood lactate dehydrogenase increased, cardiac arrest (What is cardiac arrest?), hepatotoxicity. Rocaltrol dosage: (oral). During the same period patient was treated with MARCUMAR ((oral)) (View Marcumar Review and Marcumar Label ), TORSEMIDE ((10 Mg Qd Oral)) (View Torsemide Review and Torsemide Label ), AMARYL ((2 Mg Qd Oral)) (View Amaryl Review and Amaryl Label ), CODIPRONT MONO (CODEINE POLISTIREX) ((60 Gtt Qd Oral)) (View Codipront Mono (codeine Polistirex) Review and Codipront Mono (codeine Polistirex) Label ), DECORTIN H (PREDNISOLONE) ((5 Mg Qd Oral)) (View Decortin H (prednisolone) Review and Decortin H (prednisolone) Label ), FENOFIBRATE ((200 Mg Qd Oral)) (View Fenofibrate Review and Fenofibrate Label ), GLUCOBAY ((100 Mg Tid Oral)) (View Glucobay Review and Glucobay Label ), TRACLEER ((62.5 Mg Bid Oral)) (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6215503-7 | Arthralgia, Feeling Hot, Hyperhidrosis, Loss Of Consciousness, Muscular Weakness, Pollakiuria, Thirst, Type 2 Diabetes Mellitus, Vertigo
on May 22, 2009 Female patient from CHINA , 80 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: arthralgia, feeling hot, hyperhidrosis, loss of consciousness, muscular weakness, pollakiuria, thirst, type 2 diabetes mellitus, vertigo. Rocaltrol dosage: (0.25 Ug Qd Oral). During the same period patient was treated with CALTRATE + D /00944201/ (View Caltrate + D /00944201/ Review and Caltrate + D /00944201/ Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

6207780-3 | Abdominal Pain, Anuria, Blood Creatinine Increased, Blood Potassium Increased, Coagulation Test Abnormal, Hepatic Failure, Hypoglycaemia, Inflammation, International Normalised Ratio Increased
Patient was taking Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anuria, blood creatinine increased, blood potassium increased, coagulation test abnormal, hepatic failure, hypoglycaemia, inflammation, international normalised ratio increased on May 07, 2009 from GERMANY Additional patient health information: Female patient , 62 years of age, . Rocaltrol dosage: Oral. During the same period patient was treated with MARCUMAR (Oral) (View Marcumar Review and Marcumar Label ), TORSEMIDE (10 Mg Qd Oral) (View Torsemide Review and Torsemide Label ), AMARYL (2 Mg Qd Oral) (View Amaryl Review and Amaryl Label ), CODIPRONT MONO (CODEINE POLISTIREX) (60 Gtt Qd Oral) (View Codipront Mono (codeine Polistirex) Review and Codipront Mono (codeine Polistirex) Label ), DECORTIN H (PREDNISOLONE) (5 Mg Qd Oral) (View Decortin H (prednisolone) Review and Decortin H (prednisolone) Label ), FENOFIBRATE (200 Mg Qd Oral) (View Fenofibrate Review and Fenofibrate Label ), GLUCOBAY (100 Mg Tid Oral) (View Glucobay Review and Glucobay Label ), TRACLEER (62.5 Mg Bid Oral) (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6165893-9 | Abasia, Azotaemia, Condition Aggravated, Renal Transplant
Adverse event was reported on Apr 08, 2009 by a Male patient taking Rocaltrol (View Usage) (Dosage: (0.25 ?g Oral), (0.5 ?g Qd Oral), (1 ?g 2x/week Oral), (2 ?g 2x/week Oral), (0.25 ?g 1x/week O) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: CHINA , 37 years of age, weighting 114.6 lb, Patient had the following side effects: abasia, azotaemia, condition aggravated, renal transplant. During the same period patient was treated with CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ). Patient was hospitalized.

6043865-2 | Erythema Multiforme
on Dec 19, 2007 Male patient from UNITED STATES , 74 years of age, was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: erythema multiforme. Rocaltrol dosage: (df).

6043864-0 | Throat Irritation
on Mar 03, 2004 Female patient from UNITED STATES , 55 years of age, was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: throat irritation. Rocaltrol dosage: (df Oral).

6043811-1 | Hypercalcaemia, Vomiting
Patient was taking Rocaltrol (View Usage). Patient had the following side effects: hypercalcaemia, vomiting on May 17, 2001 from UNITED STATES Additional patient health information: Female patient , weighting 39.70 lb, . Rocaltrol dosage: (1.6 Ug Qd Oral). Patient was hospitalized.

6011502-9 | Angioedema, Obstructive Airways Disorder, Respiratory Distress
Adverse event was reported on Jan 11, 1996 by a Female patient taking Rocaltrol (View Usage) (Dosage: Dose And Units Reported As: 25o Rg) was diagnosed with hypertension and. Location: AUSTRALIA , 57 years of age, weighting 176.4 lb, After Rocaltrol was administered, patient had the following side effects: angioedema, obstructive airways disorder, respiratory distress. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LOPID (View Lopid Review and Lopid Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), ISORDIL (View Isordil Review and Isordil Label ).

5989905-8 | Sexual Dysfunction
on Nov 24, 2008 Male patient from CHINA , 56 years of age, was diagnosed with hyperparathyroidism and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: sexual dysfunction. Rocaltrol dosage: (0.25 Ug 2x/week Oral). During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

5989672-8 | Condition Aggravated, Dyspepsia, Muscle Spasms, No Therapeutic Response, Osteonecrosis, Regurgitation, Renal Failure, Renal Transplant
on Nov 21, 2008 Male patient from CHINA , weighting 132.3 lb, was diagnosed with calcium deficiency, renal transplant and was treated with Rocaltrol (View Usage). Patient had the following side effects: condition aggravated, dyspepsia, muscle spasms, no therapeutic response, osteonecrosis (What is osteonecrosis?), regurgitation, renal failure, renal transplant. Rocaltrol dosage: . During the same period patient was treated with CELLCEPT ((1.5 G Oral)) (View Cellcept Review and Cellcept Label ), PREDNISONE (Df) (View Prednisone Review and Prednisone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

5955460-1 | Condition Aggravated, Dyspepsia, Hyperchlorhydria, Muscle Spasms, No Therapeutic Response, Regurgitation, Renal Failure, Renal Transplant, Surgical Procedure Repeated
Patient was taking Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: condition aggravated, dyspepsia, hyperchlorhydria, muscle spasms, no therapeutic response, regurgitation, renal failure, renal transplant, surgical procedure repeated on Oct 31, 2008 from CHINA Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with calcium deficiency, renal transplant and. Rocaltrol dosage: . During the same period patient was treated with CELLCEPT ((1.5 G Oral)) (View Cellcept Review and Cellcept Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MEDROL (View Medrol Review and Medrol Label ).

5948014-4 | Anaemia, Arthralgia, Bone Pain, Diarrhoea, Fall, Hyperparathyroidism, Hypophagia, Hypovitaminosis, Labyrinthitis
Adverse event was reported on Oct 23, 2008 by a Female patient taking Rocaltrol (View Usage) (Dosage: (0.5 ?g Qd Oral)) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: BRAZIL , 75 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, arthralgia, bone pain, diarrhoea, fall (What is fall?), hyperparathyroidism, hypophagia, hypovitaminosis, labyrinthitis. During the same period patient was treated with BONVIVA /01304701/ (BONVIVA IBANDRONIC ACID) 150 MG (NOT SPECIFIED) ((150 Mg 1x/month Oral)) (View Bonviva /01304701/ (bonviva - Ibandronic Acid) 150 Mg (not Specified) Review and Bonviva /01304701/ (bonviva - Ibandronic Acid) 150 Mg (not Specified) Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), VYTORIN (View Vytorin Review and Vytorin Label ), NOVALGINA (View Novalgina Review and Novalgina Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), EXELON /01383201/ (View Exelon /01383201/ Review and Exelon /01383201/ Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

5948014-4 | Anaemia, Arthralgia, Bone Pain, Diarrhoea, Fall, Hyperparathyroidism, Hypophagia, Hypovitaminosis, Labyrinthitis
on Oct 23, 2008 Female patient from BRAZIL , 75 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). Patient had the following side effects: anaemia, arthralgia, bone pain, diarrhoea, fall (What is fall?), hyperparathyroidism, hypophagia, hypovitaminosis, labyrinthitis. Rocaltrol dosage: (0.5 ?g Qd Oral). During the same period patient was treated with BONIVA ((150 Mg 1x/month Oral)) (View Boniva Review and Boniva Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), VYTORIN (View Vytorin Review and Vytorin Label ), NOVALGINA (View Novalgina Review and Novalgina Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), EXELON (View Exelon Review and Exelon Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

5921252-2 | Cardiac Disorder, Dyspnoea, Malaise, Pallor, Product Quality Issue, Syncope
on Sep 26, 2008 Male patient from BRAZIL , 19 years of age, weighting 198.4 lb, was diagnosed with thyroidectomy and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: cardiac disorder, dyspnoea, malaise, pallor, product quality issue, syncope. Rocaltrol dosage: (1 Ug Qd Oral). During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

5893089-4 | Cardiomyopathy, Cerebrovascular Accident, Muscle Strain, Skin Disorder
Patient was taking Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?), cerebrovascular accident, muscle strain, skin disorder on Sep 11, 2008 from BRAZIL Additional patient health information: Female patient , 73 years of age, weighting 180.8 lb, was diagnosed with thyroid disorder and. Rocaltrol dosage: . During the same period patient was treated with EUTHYROX (Dosage Regimen Reported As 1x/ Day.) (View Euthyrox Review and Euthyrox Label ), DIURESIN SR (View Diuresin Sr Review and Diuresin Sr Label ). Patient was hospitalized.

5891603-6 | Anaphylactic Reaction, Diarrhoea, Flushing, Stridor, Vomiting
Adverse event was reported on Sep 10, 2008 by a Male patient taking Rocaltrol (View Usage) (Dosage: Form: Gel Capsule) was diagnosed with ill-defined disorder and. Location: AUSTRALIA , weighting 17.64 lb, Patient had the following side effects: anaphylactic reaction, diarrhoea, flushing, stridor, vomiting.

5823026-X | Urinary Incontinence
on Jul 17, 2008 Male patient from SPAIN , 74 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: urinary incontinence (What is urinary incontinence?). Rocaltrol dosage: . During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), PREVENCOR (Form: Film Coated Tablet) (View Prevencor Review and Prevencor Label ), ASPIRIN (Form: Coated Tablets) (View Aspirin Review and Aspirin Label ), ARTEDIL (View Artedil Review and Artedil Label ), VALS (Form: Film Coated Tablet) (View Vals Review and Vals Label ).

5762940-0 | Heart Rate Increased
on May 28, 2008 Female patient from CHINA , 71 years of age, weighting 99.21 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased. Rocaltrol dosage: . During the same period patient was treated with CHINESE MEDICINE NOS (View Chinese Medicine Nos Review and Chinese Medicine Nos Label ).

5749879-1 | Gait Disturbance, Heart Rate Increased, Muscular Weakness, Osteoporosis
Patient was taking Rocaltrol (View Usage). Patient had the following side effects: gait disturbance, heart rate increased, muscular weakness, osteoporosis (What is osteoporosis?) on May 15, 2008 from CHINA Additional patient health information: Female patient , 71 years of age, weighting 99.21 lb, . Rocaltrol dosage: . During the same period patient was treated with CHINESE MEDICINE NOS (View Chinese Medicine Nos Review and Chinese Medicine Nos Label ).

5742913-4 | Hypercalcaemia, Renal Impairment
Adverse event was reported on May 07, 2008 by a Female patient taking Rocaltrol (View Usage) (Dosage: ) was diagnosed with osteoporosis prophylaxis, pain (What is pain?) and. Location: JAPAN , weighting 112.4 lb, After Rocaltrol was administered, patient had the following side effects: hypercalcaemia, renal impairment. During the same period patient was treated with BONALON (View Bonalon Review and Bonalon Label ), ALOSITOL (View Alositol Review and Alositol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TAKEPRON (View Takepron Review and Takepron Label ), PL (View Pl Review and Pl Label ).

5704633-1 | Hypercalcaemia, Renal Impairment
on Apr 02, 2008 Female patient from JAPAN , weighting 112.4 lb, was diagnosed with osteoporosis prophylaxis, pain (What is pain?) and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia, renal impairment. Rocaltrol dosage: . During the same period patient was treated with BONALON (View Bonalon Review and Bonalon Label ), ALOSITOL (View Alositol Review and Alositol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TAKEPRON (View Takepron Review and Takepron Label ).

5689248-6 | Hypercalcaemia, Renal Impairment
on Mar 17, 2008 Female patient from JAPAN , 78 years of age, weighting 112.4 lb, was diagnosed with osteoporosis prophylaxis, pain (What is pain?) and was treated with Rocaltrol (View Usage). Patient had the following side effects: hypercalcaemia, renal impairment. Rocaltrol dosage: . During the same period patient was treated with BONALON (View Bonalon Review and Bonalon Label ), ALOSITOL (View Alositol Review and Alositol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TAKEPRON (View Takepron Review and Takepron Label ), PL (View Pl Review and Pl Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5669718-7 | Blood Urea Increased, Cardiovascular Insufficiency, Dementia Alzheimer's Type, Dry Mouth, Eating Disorder, Pneumonia, Sinusitis, Tongue Disorder
Patient was taking Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: blood urea increased, cardiovascular insufficiency, dementia alzheimer's type, dry mouth, eating disorder (What is eating disorder?), pneumonia (What is pneumonia?), sinusitis (What is sinusitis?), tongue disorder on Mar 07, 2008 from BRAZIL Additional patient health information: Female patient , 92 years of age, weighting 132.3 lb, was diagnosed with osteoporosis (What is osteoporosis?), mineral supplementation, depression (What is depression?), cardiomegaly, chronic obstructive pulmonary disease and. Rocaltrol dosage: Unk, Bid. During the same period patient was treated with CALTRATE (Unk, Qd) (View Caltrate Review and Caltrate Label ), DAFLON (DIOSMIN) (500 Mg, Bid) (View Daflon (diosmin) Review and Daflon (diosmin) Label ), ASCORBIC ACID (500 Mg, Qd) (View Ascorbic Acid Review and Ascorbic Acid Label ), CLORANA (25 Mg, Qd) (View Clorana Review and Clorana Label ), AAS (Unk, Qd) (View Aas Review and Aas Label ), SERTRALINE HYDROCHLORIDE (40 Mg, Qd) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), DIGOXIN (0.12 Mg, Qd) (View Digoxin Review and Digoxin Label ), FORASEQ (1-2 Df/q12h) (View Foraseq Review and Foraseq Label ). Patient was hospitalized.

5647239-5 | Cerebral Infarction
Adverse event was reported on Feb 21, 2008 by a Female patient taking Rocaltrol (View Usage) (Dosage: Indication Acalcicosis Form Reported As Soft Capsule) was diagnosed with hypertension and. Location: CHINA , 56 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: cerebral infarction. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

5629932-3 | Osteonecrosis
on Feb 04, 2008 Male patient from CHINA , 50 years of age, weighting 156.5 lb, was diagnosed with bone pain, renal transplant and was treated with Rocaltrol (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Rocaltrol dosage: Form Soft Capsule, Other Indication Calcium Deficiency. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TALCID (View Talcid Review and Talcid Label ).

5581316-2 | Blood Urea Increased, Cardiovascular Insufficiency, Dementia Alzheimer's Type, Dry Mouth, Eating Disorder, Pneumonia, Sinusitis, Tongue Disorder
on Dec 27, 2007 Female patient from BRAZIL , 92 years of age, weighting 132.3 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: blood urea increased, cardiovascular insufficiency, dementia alzheimer's type, dry mouth, eating disorder (What is eating disorder?), pneumonia (What is pneumonia?), sinusitis (What is sinusitis?), tongue disorder. Rocaltrol dosage: Unk, Bid. During the same period patient was treated with CALTRATE (Unk, Qd) (View Caltrate Review and Caltrate Label ), DAFLON (DIOSMIN) (500 Mg, Bid) (View Daflon (diosmin) Review and Daflon (diosmin) Label ), ASCORBIC ACID (500 Mg, Qd) (View Ascorbic Acid Review and Ascorbic Acid Label ), CLORANA (25 Mg, Qd) (View Clorana Review and Clorana Label ), AAS (Unk, Qd) (View Aas Review and Aas Label ), SERTRALINE HYDROCHLORIDE (40 Mg, Qd) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), DIGOXIN (0.12 Mg, Qd) (View Digoxin Review and Digoxin Label ), FORASEQ (1-2 Df/q12h) (View Foraseq Review and Foraseq Label ). Patient was hospitalized.

5490830-X | Blood Creatinine Increased, Diarrhoea, Glomerular Filtration Rate Decreased, Nausea
Patient was taking Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, diarrhoea, glomerular filtration rate decreased, nausea (What is nausea?) on Oct 08, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 87 years of age, was diagnosed with calcium deficiency and. Rocaltrol dosage: .

5475515-8 | Hypercalcaemia
Adverse event was reported on Oct 22, 2006 by a Female patient taking Rocaltrol (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, weighting 158.1 lb, Patient had the following side effects: hypercalcaemia. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ALLEGRA (FEXOFENADINE HYDROCHLORIDE) (View Allegra (fexofenadine Hydrochloride) Review and Allegra (fexofenadine Hydrochloride) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), VITAMIN D (VITAMIN D NOS) (View Vitamin D (vitamin D Nos) Review and Vitamin D (vitamin D Nos) Label ). Patient was hospitalized.

5418211-5 | Blood Parathyroid Hormone Increased, Therapeutic Product Contamination
on Aug 07, 2007 Male patient from UNITED STATES , child 3 years of age, weighting 28.66 lb, was diagnosed with hyperparathyroidism and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: blood parathyroid hormone increased, therapeutic product contamination. Rocaltrol dosage: The Patient Received Increasing Doses. Formulation Reported As Liquid.. During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

5391420-X | Venous Thrombosis
on Jul 11, 2007 Female patient from JAPAN , 74 years of age, weighting 119.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: venous thrombosis. Rocaltrol dosage: . During the same period patient was treated with EVISTA (View Evista Review and Evista Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MYSLEE (View Myslee Review and Myslee Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

5390212-5 | Blood Parathyroid Hormone Increased, Therapeutic Product Contamination
Patient was taking Rocaltrol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, therapeutic product contamination on Jul 10, 2007 from UNITED STATES Additional patient health information: Male patient , child 3 years of age, weighting 28.88 lb, was diagnosed with hyperparathyroidism and. Rocaltrol dosage: The Patient Received Increasing Doses. Formulation Reported As Liquid.. During the same period patient was treated with FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

5378611-9 | Blood Parathyroid Hormone Increased, Therapeutic Product Contamination
Adverse event was reported on Jun 27, 2007 by a Male patient taking Rocaltrol (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism and. Location: UNITED STATES , child 3 years of age, After Rocaltrol was administered, patient had the following side effects: blood parathyroid hormone increased, therapeutic product contamination. During the same period patient was treated with FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

5377486-1 | Embolism Venous
on Jun 21, 2007 Female patient from JAPAN , 74 years of age, was diagnosed with osteoporosis postmenopausal and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: embolism venous. Rocaltrol dosage: . During the same period patient was treated with EVISTA (View Evista Review and Evista Label ), GASTER (View Gaster Review and Gaster Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

5372147-7 | Blood Parathyroid Hormone Increased, Therapeutic Product Contamination
on Jun 15, 2007 Male patient from UNITED STATES , child 3 years of age, was diagnosed with hyperparathyroidism and was treated with Rocaltrol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, therapeutic product contamination. Rocaltrol dosage: . During the same period patient was treated with FERROUS SULFATE (Formulation Reported As Ferrous Sulfate Liquid.) (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

5363712-1 | Blood Glucose Increased, Hyperphosphataemia, Hypocalcaemia, Pitting Oedema
Patient was taking Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: blood glucose increased, hyperphosphataemia, hypocalcaemia, pitting oedema on Jun 11, 2007 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 229.1 lb, was diagnosed with calcium metabolism disorder and. Rocaltrol dosage: . During the same period patient was treated with OS CAL (View Os-cal Review and Os-cal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), DEMADEX (View Demadex Review and Demadex Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), LANTUS (Reported As 100units/ml) (View Lantus Review and Lantus Label ). Patient was hospitalized.

5322206-X | Anaphylactic Shock
Adverse event was reported on May 02, 2007 by a Male patient taking Rocaltrol (View Usage) (Dosage: ) was diagnosed with hypocalcaemia and. Location: JAPAN , 46 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with CALCICOL (Route: Intravenous (not Otherwise Specified).) (View Calcicol Review and Calcicol Label ), FESIN (Route: Intravenous (not Otherwise Specified).) (View Fesin Review and Fesin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALTAN (View Caltan Review and Caltan Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MYSLEE (View Myslee Review and Myslee Label ), ALFAROL (View Alfarol Review and Alfarol Label ).

5319064-6 | Blood Glucose Increased, Hyperphosphataemia, Hypocalcaemia, Pitting Oedema
on Apr 27, 2007 Female patient from UNITED STATES , 37 years of age, weighting 229.1 lb, was diagnosed with calcium metabolism disorder and was treated with Rocaltrol (View Usage). Patient had the following side effects: blood glucose increased, hyperphosphataemia, hypocalcaemia, pitting oedema. Rocaltrol dosage: . During the same period patient was treated with OS CAL (View Os-cal Review and Os-cal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), DEMADEX (View Demadex Review and Demadex Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), LANTUS (View Lantus Review and Lantus Label ), PROCRIT (View Procrit Review and Procrit Label ). Patient was hospitalized.

5317111-9 | Anaphylactic Shock
on Apr 24, 2007 Male patient from JAPAN , 46 years of age, weighting 108.0 lb, was diagnosed with hypocalcaemia and was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: anaphylactic shock. Rocaltrol dosage: . During the same period patient was treated with CALCICOL (Route: Intravenous (not Otherwise Specified).) (View Calcicol Review and Calcicol Label ), FESIN (Route: Intravenous (not Otherwise Specified).) (View Fesin Review and Fesin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALTAN (View Caltan Review and Caltan Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MYSLEE (View Myslee Review and Myslee Label ), ALFAROL (View Alfarol Review and Alfarol Label ).

5308734-1 | Anaphylactic Shock
Patient was taking Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock on Apr 17, 2007 from JAPAN Additional patient health information: Male patient , 46 years of age, weighting 108.0 lb, was diagnosed with hypocalcaemia and. Rocaltrol dosage: . During the same period patient was treated with CALCICOL (Route: Intravenous (not Otherwise Specified).) (View Calcicol Review and Calcicol Label ), FESIN (Route: Intravenous (not Otherwise Specified).) (View Fesin Review and Fesin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALTAN (View Caltan Review and Caltan Label ), MUCOSTA (Frequency Reported As 1/1/ Day And Also Prn. Reported Note: Single Use) (View Mucosta Review and Mucosta Label ), MYSLEE (Frequency Reported As Prn And 1/1 Day) (View Myslee Review and Myslee Label ), ALFAROL (View Alfarol Review and Alfarol Label ).

5304360-9 | Anaphylactic Shock
Adverse event was reported on Apr 13, 2007 by a Male patient taking Rocaltrol (View Usage) (Dosage: ) was diagnosed with hypocalcaemia and. Location: JAPAN , 46 years of age, weighting 108.0 lb, Patient had the following side effects: anaphylactic shock. During the same period patient was treated with CALCICOL (Route: Intravenous (not Otherwise Specified).) (View Calcicol Review and Calcicol Label ), FESIN (Route: Intravenous (not Otherwise Specified).) (View Fesin Review and Fesin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALTAN (View Caltan Review and Caltan Label ), MUCOSTA (Frequency Reported As 1/1/ Day And Also Prn. Reported Note: Single Use) (View Mucosta Review and Mucosta Label ), MYSLEE (Frequency Reported As Prn And 1/1 Day) (View Myslee Review and Myslee Label ), ALFAROL (View Alfarol Review and Alfarol Label ).

5303202-5 | Tachycardia
on Apr 11, 2007 Female patient from UNITED STATES , 34 years of age, weighting 121.3 lb, was treated with Rocaltrol (View Usage). After Rocaltrol was administered, patient had the following side effects: tachycardia. Rocaltrol dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ZANTAC (View Zantac Review and Zantac Label ), VALCYTE (View Valcyte Review and Valcyte Label ). Patient was hospitalized.

5275966-0 | Anaphylactic Shock
on Mar 16, 2007 Male patient from JAPAN , 46 years of age, weighting 108.0 lb, was diagnosed with hypocalcaemia and was treated with Rocaltrol (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Rocaltrol dosage: . During the same period patient was treated with CALCICOL (Route: Intravenous (not Otherwise Specified).) (View Calcicol Review and Calcicol Label ), FESIN (Route: Intravenous (not Otherwise Specified).) (View Fesin Review and Fesin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALTAN (View Caltan Review and Caltan Label ), MUCOSTA (Frequency Reported As 1/1/ Day And Also Prn) (View Mucosta Review and Mucosta Label ), MYSLEE (Frequency Reported As Prn And 1/1 Day) (View Myslee Review and Myslee Label ), ALFAROL (View Alfarol Review and Alfarol Label ).

5275962-3 | Adenoidectomy, Enuresis, Keratitis, Paracentesis
Patient was taking Rocaltrol (View Usage). Patient had the following side effects: adenoidectomy, enuresis, keratitis, paracentesis on Mar 14, 2007 from GERMANY Additional patient health information: Female patient , child 5 years of age, weighting 40.57 lb, was diagnosed with hypoparathyroidism and. Rocaltrol dosage: Dosage Regimen Reported As 1 X 0.25 Mcg. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ). Patient was hospitalized.